Traders should monitor for potential downward pressure on DGX shares, especially if no offsetting institutional buying emerges. The concentration of C-suite selling on a single day is a negative signal, particularly in absence of recent positive news.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 5 $203.09entry
- T+1 · 9mo ago −2.34%α −1.03% · $198.34
- T+5 · 8mo ago −1.52%α +0.72% · $200.01
- T+20 · 8mo ago −2.92%α +0.87% · $197.16
- T+60 · 6mo ago −5.36%α −16.66% · $192.20
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Quest Diagnostics executives sold shares in a coordinated open-market transaction on March 5, 2026, totaling approximately $2.53 million. The sales were conducted at $206.21 per share and represent a material insider selling cluster. A director also received a non-cash award of 215 shares on March 9.
Key Financial Metrics
Key Facts
- SVP Patrick Plewman sold 2,855 shares for $588,729.55
- EVP Catherine Doherty sold 5,558 shares for $1,146,115.18
- SVP Michael Prevoznik sold 3,878 shares for $799,682.38
- Total open-market sales: $2,534,527.11 across three C-suite executives
- All sales occurred on March 5, 2026, at $206.21 per share
- Director Timothy Wentworth received 215 shares via non-cash grant on March 9, 2026
Financial Impact
$2.53 million in open-market insider sales, representing ~0.011% of Quest Diagnostics' $22.1B market cap
Risk Factors
- Insider selling may indicate lack of confidence in near-term performance or valuation
- Potential for negative market perception leading to short-term share price weakness
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-DGX-1773266891498 |
Track record
24 reports on DGX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $259.60 +0.00% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $259.60 +0.35% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $259.60 +0.45% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $259.60 +1.55% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $259.60 +5.69% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers